RetaLog icon — a vial beside a log list RetaLog
Retatrutide Tracker · Android

One compound.
One log. RetaLog.

RetaLog is a personal tracking and education tool built for retatrutide only. Log each injection — split doses included — follow your estimated level curve on the ~6-day half-life model, track vials and run-out dates, and keep symptoms and resting heart rate alongside. No account. No ads. Everything stays on your device.

RetaLog is coming soon to Google Play. Until it lands, Vialera — our peptide tracker, live on Google Play now — already includes retatrutide tracking, and RetaLog restores Vialera backups, so nothing you log is lost when you switch.

RetaLog home screen: weekly calendar, a Retatrutide Focus card, today's schedule and estimated levels
RetaLog home — your week, schedule and estimated levels on one screen.

Investigational — not FDA-approved

Retatrutide is an investigational medicine. It is not approved by the FDA or any other regulator, and outside its clinical trials there is no legitimate retail sale for human use.

RetaLog is a personal tracking and education tool. It does not sell anything, does not link to any seller, and does not provide medical advice, diagnosis, treatment, or dose recommendations. Every amount in this app is entered by you. Talk to a qualified clinician about any protocol, and about whether any compound is legal or appropriate for you.

Built for one compound, done properly

General peptide trackers spread themselves across a hundred compounds. RetaLog is designed around retatrutide alone — its ~6-day half-life, its weekly rhythm, its record-keeping.

Injection & split-dose log

Log each injection as you take it — split doses included — with site rotation so no spot gets overused. Every amount is yours; the app suggests nothing.

Estimated level curve

Your estimated level, modeled on retatrutide's ~6-day half-life and charted from the doses you actually logged — so the week ahead reads at a glance.

Vial tracker & run-out forecast

Vial and pen inventory with remaining amounts and run-out dates — you know when a vial runs out long before it does.

Reconstitution calculator

Your numbers, your math. Enter the vial and the water; RetaLog does the arithmetic. No suggested amounts, ever.

Symptoms & heart rate

A symptom and resting heart-rate log kept beside your doses — your own records, in your own words. The app never interprets them or flags them.

Cited research view

TRIUMPH trial information and pharmacokinetics, presented as published trial information — never as a recommended schedule.

Inside the app

Real screens from RetaLog. Dark, quiet, and built to be checked in seconds — not scrolled for minutes.

How you feel, on the record

Symptom & resting heart-rate log

Retatrutide's trial-reported effects — like skin sensitivity — are easier to spot in a written record than in memory. Log what you feel, when it started, and your resting heart rate beside it. RetaLog stores it and stays out of the interpretation business: if you feel unwell, it tells you to talk to a qualified healthcare professional.

RetaLog symptom log form: date, related compound, symptom, severity, and resting heart rate
Logging a symptom — your words, your record.
Education, cited

The research view

What the trials actually reported, with the investigational warning at the top of the page — not buried under it. Published results are shown as research information, never as a promise of any individual's result, and never as a dosing guide.

RetaLog research summary screen with an investigational warning banner and published TRIUMPH trial information
The research summary — warning first, trial data second.
RetaLog's first-run disclosure: 'Retatrutide is investigational — please read', shown before any logging
The first thing RetaLog shows you — before any logging.

The warning comes first — in the app, too

RetaLog opens with the disclosure on the left, and you tap “I understand” before you log a single thing. That posture runs through everything we publish about this app:

  • Investigational, stated plainlyRetatrutide is not approved by the FDA or any other regulator. RetaLog never presents it as an approved medicine.
  • Nothing to buy, nobody to buy fromThe app sells nothing and links to no seller. This site doesn't either — the only store link here is to Vialera, our own tracker app.
  • No medical advice, no dose recommendationsRetaLog records what you enter and shows published research. Whether any compound is legal or appropriate for you is a question for a qualified clinician.
  • No affiliationRetaLog has no affiliation with Eli Lilly — the company developing retatrutide — or with any other company, and receives nothing from any of them.

Private by design

No account. No ads. No analytics. No data sale. RetaLog doesn't even hold an internet permission — everything you log stays on your device, works fully offline, and uninstalling deletes it. This website collects nothing either: no cookies, no trackers.

Read the privacy policy

RetaLog is coming soon.

Vialera is here now — and its retatrutide mode is the same tracking, live on Google Play today. Start there, and RetaLog will pick up your history when it launches.

Get Vialera on Google Play

RetaLog launches at $0.99 on Google Play, with an optional Pro subscription for level history and exports. Android first.